NOT KNOWN FACTUAL STATEMENTS ABOUT AV-101

Nacubactam has some intrinsic antibacterial activity as a result of PBP2 inhibition [141]. It seems to acquire superior in vivo action from AmpC-overproducing and Klebsiella pneumoniaeA new analysis based upon the EARS-Web data highlighted that international locations reporting superior proportions of P. aeruginosa, MICs of zidebactam and cefepime/